Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 11,458 shares at $26.75 ($307K) on 2021-11-02, disclosed to the SEC on 2021-11-04.
Open-market sale of $307k TARS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.75 | 5,458 | $146K | 47.6% |
| 2 | $26.75 | 5,458 | $146K | 47.6% |
| 3 | $27.07 | 542 | $15K | 4.8% |
| Total | $26.77 avg | 11,458 | $307K | 100% |
| Filing → |
| TARS | SELL | 2025-03-20 | $1.0M | — | Filing → |
| TARS | SELL | 2024-03-19 | $292K | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |